Nickel compounds render anti-apoptotic effect to human bronchial epithelial beas-2B cells by induction of cyclooxygenase-2 through an IKKβ/p65- dependent and IKKα- and p50-independent pathway

Journal of Biological Chemistry

Volumn 281, Issue 51, 2006, Pages 39022-39032

  Ding, Jin ^a   Zhang, Xinhai ^a   Li, Jingxia ^a   Song, Lun ^a   Ouyang, Weiming ^a   Zhang, Dongyun ^a   Xue, Caifang ^b   Costa, Max ^a   Meléndez, J Andrés ^c   Huang, Chuanshu ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; NICKEL COMPOUNDS; RNA; TUMORS;

APOPTOSIS; CARCINOGENICITY; CYCLOOXYGENASE;

CARCINOGENS;

CYCLOOXYGENASE 2; HYDROGEN PEROXIDE; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NICKEL COMPLEX; PROTEIN P50; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; SYNAPTOTAGMIN I;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRONCHUS MUCOSA; CARCINOGENESIS; CELL DEATH; CELL LINE; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO CELL; FIBROBLAST; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANIMALS; APOPTOSIS; BRONCHI; CYCLOOXYGENASE 2; ENZYME ACTIVATION; EPITHELIAL CELLS; FIBROBLASTS; HUMANS; I-KAPPA B KINASE; MICE; NF-KAPPA B; NICKEL; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33846012227     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M604798200     Document Type: Article

References (59)

1. International Agency for Research on Cancer (1990) IARC Sci. Publ. 49, 257-445
2. Denkhaus, E., and Salnikow, K. (2002) Crit. Rev. Oncol. Hematol. 42, 35-36
3. Sivulka, D. J. (2005) Regul. Toxicol. Pharmacol. 43, 117-133
4. Kasprzak, K. S., Sunderman, J. F. W., and Salnikow, K. (2003) Mutat. Res. 533, 67-97
5. Cangul, H., Broday, L., Salnikow, K., Sutherland, J., Peng, W., Zhang, Q., Poltaratsky, V., Yee, H., Zoroddu, M. A., and Costa, M. (2002) Toxicol. Lett. (Amst.) 127, 69-75
6. Li, J., Davidson, G., Huang, Y., Jiang, B.-H., Shi, X., Costa, M., and Huang, C. (2004) Cancer Res. 64, 94-101
7. Salnikow, K., and Costa, M. (2000) J. Environ. Pathol. Toxicol. Oncol. 19, 307-318
8. Wyllie, A. H., Bellamy, C. O., Bubb, V. J., Clarke, A. R., Corbet, S., Curtis, L., Harrison, D. J., Hooper, M. L., Toft, N., Webb, S., and Bird, C. C. (1999) Br. J. Cancer 80, Suppl. 1, 34-37
9. Liu, Z. G., Lewis, J., Wang, T. H., and Cook, A. (2001) Methods Cell Biol. 66, 187-195
10. Subbaramaiah, K., and Dannenberg, A. J. (2003) Trends Pharmacol. Sci. 24, 96-102
11. Gasparini, G., Longo, R., Sarmiento, R., and Morabito, A. (2003) Lancet Oncol. 4, 605-615
12. Kuwano, T., Nakao, S., Yamamoto, H., Tsuneyoshi, M., Yamamoto, T., Kuwano, M., and Ono, M. (2004) FASEB J. 18, 300-310
13. Dempke, W., Rie, C., Grothey, A., and Schmoll, H. J. (2001) J. Cancer Res. Clin. Oncol. 127, 411-417
14. Dannenberg, A. J., Lippman, S. M., Mann, J. R., Subbaramaiah, K., and DuBois, R. N. (2005) J. Clin. Oncol. 23, 254-266
15. Tang, G., Minemoto, Y., Dibling, B., Purcell, N. H., Li, Z., Karin, M., and Lin, A. (2001) Nature 414, 313-317
16. Rodríguez, A. M., Carrico, P. M., Mazurkiewicz, J. E., and Meléndez, J. A. (2000) Free Radic. Biol. Med. 29, 801-813
17. Ouyang, W., Ma, Q., Li, J., Zhang, D., Liu, Z.-G., Rustgi, A. K., and Huang, C. (2005) Cancer Res. 65, 9287-9293
18. Riedl, K., Krysan, K., Pold, M., Dalwadi, H., Heuze-Vourc'h, N., Dohadwala, M., Liu, M., Cui, X., Figlin, R., Mao, J. T., Strieter, R., Sharma, S., and Dubinett, S. M. (2004) Drug Resist. Updat. 7, 169-184
19. Hogan, P. G., Chen, L., Nardone, J., and Rao, A. (2003) Genes Dev. 17, 2205-2232
20. Gorgoni, B., Caivano, M., Arizmendi, C., and Poli, V. (2001) J. Biol. Chem. 276, 40769-40777
21. Yoon, J. M., Lim, J.-J., Yoo, C.-G., Lee, C.-T., Bang, Y.-J., Han, S. K., Shim, Y.-S., and Kim, Y. W. (2005) Lung Cancer 48, 201-209
22. Weng, M.-W., Hsiao, Y.-M., Chen, C.-J., Wang, J.-P., Chen, W.-C., and Ko, J.-L. (2004) Toxicol. Lett. (Amst.) 151, 345-355
23. Karin, M., and Greten, F. R. (2005) Nat. Rev. Immunol. 5, 749-759
24. Hayden, M. S., and Ghosh, S. (2004) Genes Dev. 18, 2195-2224
25. Huang, Y., Davidson, G., Li, J., Yan, Y., Chen, F., Costa, M., Chen, L., and Huang, C. (2002) Environ. Health Perspec. 110, Suppl. 5, 835-839
26. Karin, M., and Ben-Neriah, Y. (2000) Annu. Rev. Immunol. 18, 621-663
27. Luo, J.-L., Kamata, H., and Karin, M. (2005) J. Clin. Investig. 115, 2625-2632
28. Li, L., Steinauer, K. K., Dirks, A. J., Husbeck, B., Gibbs, I., and Knox, S. J. (2003) Radiat. Res. 160, 617-621
29. Li, Z.-W., Chu, W., Hu, Y., Delhase, M., Deerinck, T., Ellisman, M., Johnson, R., and Karin, M. (1999) J. Exp. Med. 189, 1839-1845
30. Viatour, P., Merville, M.-P., Bours, V., and Chariot, A. (2005) Trends Biochem. Sci. 30, 43-52
31. Beg, A. A., Sha, W. C., Bronson, R. T., Ghosh, S., and Baltimore, D. (1995) Nature 376, 167-170
32. Baeuerle, P. A., and Baltimore, D. (1996) Cell 87, 13-20
33. Huang, C., Li, J., Costa, M., Zhang, Z., Leonard, S. S., Castranova, V., Vallyathan, V., Ju, G., and Shi, X. (2001) Cancer Res. 61, 8051-8057
34. Correa, P., and Miller, M. J. (1998) Br. Med. Bull. 54, 151-162
35. Clarke, A. R. (2000) Symp. Soc. Exp. Biol. 52, 265-275
36. Tomei, L. D., Kanter, P., and Wenner, C. E. (1988) Biochem. Biophys. Res. Commun. 155, 324-341
37. Snyder, R. D., Pullman, J., Carter, J. H., Carter, H. W., and DeAngelo, A. B. (1995) Cancer Res. 55, 3702-3705
38. Schulte-Hermann, R., Timmermann-Trosiener, I., Barthel, G., and Bursch, W. (1990) Cancer Res. 50, 5127-5135
39. Roberts, R. A., Soames, A. R., James, N. H., Gill, J. H., and Wheeldon, E. B. (1995) Toxicol. Appl. Pharmacol. 135, 192-199
40. Bursch, W., Paffe, S., Putz, B., Barthel, G., and Schulte-Hermann, R. (1990) Carcinogenesis 11, 847-853
41. Bursch, W., Oberhammer, F., and Schulte-Hermann, R. (1992) Trends Pharmacol. Sci. 13, 245-251
42. Bursch, W., Oberhammer, F., Jirtle, R. L., Askari, M., Sedivy, R., Grasl-Kraupp, B., Purchio, A. F., and Schulte-Hermann, R. (1993) Br. J. Cancer 67, 531-536
43. Pairet, M., and Engelhardt, G. (1996) Fundam. Clin. Pharmacol. 10, 1-17
44. Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., and Ben-Neriah, Y. (2004) Nature 431, 461-466
45. Clevers, H. (2004) Cell 118, 671-674
46. Szlosarek, P. W., and Balkwill, F. R. (2003) Lancet Oncol. 4, 565-573
47. Scott, K. A., Moore, R. J., Arnott, C. H., East, N., Thompson, R. G., Scallon, B. J., Shealy, D. J., and Balkwill, F. R. (2003) Mol. Cancer Ther. 2, 445-451
48. Moore, R. J., Owens, D. M., Stamp, G., Arnott, C., Burke, F., East, N., Holdsworth, H., Turner, L., Rollins, B., Pasparakis, M., Kollias, G., and Balkwill, F. (1999) Nat. Med. 5, 828-831
49. Samet, J. M., Graves, L. M., Quay, J., Dailey, L. A., Devlin, R. B., Ghio, A. J., Wu, W., Bromberg, P. A., and Reed, W. (1998) Am. J. Physiol. 275, L551-L558
50. Moynagh, P. N. (2005) J. Cell Sci. 118, 4589-4592
51. Saldana, M., Bonastre, M., Aguilar, E., and Marin, C. (2006) Eur. Neuropsychopharmacol., in press
52. Chang, P.-Y., and Miyamoto, S. (2006) Mol. Cancer Res. 4, 101-112
53. Sha, W. C., Liou, H.-C., Tuomanen, E. I., and Baltimore, D. (1995) Cell 80, 321-330
54. Dalton, T. P., Shertzer, H. G., and Puga, A. (1999) Annu. Rev. Pharmacol. Toxicol. 39, 67-101
55. Shackelford, R. E., Kaufmann, W. K., and Paules, R. S. (2000) Free Radic. Biol. Med. 28, 1387-1404
56. von Knethen, A., Callsen, D., and Brune, B. (1999) J. Immunol. 163, 2858-2866
57. Lu, H., Shi, X., Costa, M., and Huang, C. (2005) Mol. Cell. Biochem. 279, 45-67
58. Kang, J., Zhang, Y., Chen, J., Chen, H., Lin, C., Wang, Q., and Ou, Y. (2003) Toxicol. Sci. 74, 279-286
59. Harris, G. K., and Shi, X. (2003) Mutat. Res. 533, 183-200